A GEMA of a personalized medicine strategy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28539474.
- Also identified by DOI 10.1126/scitranslmed.aan4294.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A screening method can identify tumors susceptible to synthetic lethality via PARP inhibition.
Medical subject headings
- Precision Medicine